Interleukin 1 induces interleukin 1: I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro

C. A. Dinarello, T. Ikejima, S. J.C. Warner, S. F. Orencole, G. Lonnemann, J. G. Cannon, P. Libby

Research output: Contribution to journalArticle

364 Citations (Scopus)

Abstract

Interleukin 1 (IL-1) plays an important role in host defense mechanisms by increasing body temperature, inducing the synthesis of a variety of lymphokines and hepatic acute phase proteins and acting as a chemoattractant for lymphocytes. However, in some microenvironments such as injured tissue or joint spaces, elevated IL-1 levels may contribute to pathologic processes, for example, proliferation and fibrosis of tissue involved in pannus formation as well as degradation of matrix and abnormal tissue architecture. To investigate potential mechanisms that may lead to excessive production of IL-1, we have examined the ability of IL-1 to participate in an amplification event by inducing its own gene expression leading to synthesis of biologically active IL-1. When injected into rabbits, recombinant human IL-1-α induced biphasic fevers, and during the second temperature elevation 3 hr later, a circulating pyrogenic material was detected by passive transfer of plasma to other rabbits. Induction of the biphasic fever was not caused by endotoxin contamination of the recombinant IL-1. The 3-hr circulating pyrogen was heat-labile and was not residual injected IL-1-α. Chromatographic separation of this plasma and biologic assay suggested that it was new IL-1 of rabbit origin. We next incubated human blood mononuclear cells with recombinant IL-1-α and measured the intracellular and extracellular levels of IL-1 by bioassay using the D10.G4.1 murine T cell line. In order to control for the carryover of recombinant IL-1-α used to stimulate the mononuclear cells (MNC), we used neutralizing antibodies that were specific for IL-1-α or IL-1-β. The results of these neutralizations showed that recombinant human IL-1-α induces the synthesis of IL-1-β in human MNC in vitro. These results were verified with a radioimmunoassay specific for IL-1-β. At concentrations of 100 ng/ml, IL-1-α induced prostaglandin E2 production in the MNC culture, and this was associated with decreased production of immunoreactive IL-1-β. Adding indomethacin to the cultures prevented the decreased production of IL-1-β induced by high concentrations of IL-1-α. Using non-adherent MNC, we observed an increase in IL-1-β as well as IL-1-α mRNA after 4 hr of exposure to recombinant IL-1-α. These results demonstrate that IL-1-α induces biologically active and immunoreactive IL-1-β from MNC in vitro and that the same concentrations of IL-1-α induce gene expression for both forms of IL-1. These studies suggest that IL-1 participates in an amplification event that is negatively influenced by its ability to induce prostaglandin E2 synthesis. These results may have clinical implications because they suggest that cyclo-oxygenase inhibitors, which are often administered to reduce IL-1-mediated inflammation, may also interfere with an intrinsic ability of IL-1 to down-regulate its own amplification.

Original languageEnglish (US)
Pages (from-to)1902-1910
Number of pages9
JournalJournal of Immunology
Volume139
Issue number6
StatePublished - Nov 24 1987

Fingerprint

Interleukin-1
Rabbits
In Vitro Techniques
Dinoprostone
Biological Assay
Fever

ASJC Scopus subject areas

  • Immunology

Cite this

Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987). Interleukin 1 induces interleukin 1: I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. Journal of Immunology, 139(6), 1902-1910.

Interleukin 1 induces interleukin 1 : I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. / Dinarello, C. A.; Ikejima, T.; Warner, S. J.C.; Orencole, S. F.; Lonnemann, G.; Cannon, J. G.; Libby, P.

In: Journal of Immunology, Vol. 139, No. 6, 24.11.1987, p. 1902-1910.

Research output: Contribution to journalArticle

Dinarello, CA, Ikejima, T, Warner, SJC, Orencole, SF, Lonnemann, G, Cannon, JG & Libby, P 1987, 'Interleukin 1 induces interleukin 1: I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro', Journal of Immunology, vol. 139, no. 6, pp. 1902-1910.
Dinarello CA, Ikejima T, Warner SJC, Orencole SF, Lonnemann G, Cannon JG et al. Interleukin 1 induces interleukin 1: I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. Journal of Immunology. 1987 Nov 24;139(6):1902-1910.
Dinarello, C. A. ; Ikejima, T. ; Warner, S. J.C. ; Orencole, S. F. ; Lonnemann, G. ; Cannon, J. G. ; Libby, P. / Interleukin 1 induces interleukin 1 : I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. In: Journal of Immunology. 1987 ; Vol. 139, No. 6. pp. 1902-1910.
@article{ec3e2deca81846f7a48897e2d7dd02a7,
title = "Interleukin 1 induces interleukin 1: I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro",
abstract = "Interleukin 1 (IL-1) plays an important role in host defense mechanisms by increasing body temperature, inducing the synthesis of a variety of lymphokines and hepatic acute phase proteins and acting as a chemoattractant for lymphocytes. However, in some microenvironments such as injured tissue or joint spaces, elevated IL-1 levels may contribute to pathologic processes, for example, proliferation and fibrosis of tissue involved in pannus formation as well as degradation of matrix and abnormal tissue architecture. To investigate potential mechanisms that may lead to excessive production of IL-1, we have examined the ability of IL-1 to participate in an amplification event by inducing its own gene expression leading to synthesis of biologically active IL-1. When injected into rabbits, recombinant human IL-1-α induced biphasic fevers, and during the second temperature elevation 3 hr later, a circulating pyrogenic material was detected by passive transfer of plasma to other rabbits. Induction of the biphasic fever was not caused by endotoxin contamination of the recombinant IL-1. The 3-hr circulating pyrogen was heat-labile and was not residual injected IL-1-α. Chromatographic separation of this plasma and biologic assay suggested that it was new IL-1 of rabbit origin. We next incubated human blood mononuclear cells with recombinant IL-1-α and measured the intracellular and extracellular levels of IL-1 by bioassay using the D10.G4.1 murine T cell line. In order to control for the carryover of recombinant IL-1-α used to stimulate the mononuclear cells (MNC), we used neutralizing antibodies that were specific for IL-1-α or IL-1-β. The results of these neutralizations showed that recombinant human IL-1-α induces the synthesis of IL-1-β in human MNC in vitro. These results were verified with a radioimmunoassay specific for IL-1-β. At concentrations of 100 ng/ml, IL-1-α induced prostaglandin E2 production in the MNC culture, and this was associated with decreased production of immunoreactive IL-1-β. Adding indomethacin to the cultures prevented the decreased production of IL-1-β induced by high concentrations of IL-1-α. Using non-adherent MNC, we observed an increase in IL-1-β as well as IL-1-α mRNA after 4 hr of exposure to recombinant IL-1-α. These results demonstrate that IL-1-α induces biologically active and immunoreactive IL-1-β from MNC in vitro and that the same concentrations of IL-1-α induce gene expression for both forms of IL-1. These studies suggest that IL-1 participates in an amplification event that is negatively influenced by its ability to induce prostaglandin E2 synthesis. These results may have clinical implications because they suggest that cyclo-oxygenase inhibitors, which are often administered to reduce IL-1-mediated inflammation, may also interfere with an intrinsic ability of IL-1 to down-regulate its own amplification.",
author = "Dinarello, {C. A.} and T. Ikejima and Warner, {S. J.C.} and Orencole, {S. F.} and G. Lonnemann and Cannon, {J. G.} and P. Libby",
year = "1987",
month = "11",
day = "24",
language = "English (US)",
volume = "139",
pages = "1902--1910",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Interleukin 1 induces interleukin 1

T2 - I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro

AU - Dinarello, C. A.

AU - Ikejima, T.

AU - Warner, S. J.C.

AU - Orencole, S. F.

AU - Lonnemann, G.

AU - Cannon, J. G.

AU - Libby, P.

PY - 1987/11/24

Y1 - 1987/11/24

N2 - Interleukin 1 (IL-1) plays an important role in host defense mechanisms by increasing body temperature, inducing the synthesis of a variety of lymphokines and hepatic acute phase proteins and acting as a chemoattractant for lymphocytes. However, in some microenvironments such as injured tissue or joint spaces, elevated IL-1 levels may contribute to pathologic processes, for example, proliferation and fibrosis of tissue involved in pannus formation as well as degradation of matrix and abnormal tissue architecture. To investigate potential mechanisms that may lead to excessive production of IL-1, we have examined the ability of IL-1 to participate in an amplification event by inducing its own gene expression leading to synthesis of biologically active IL-1. When injected into rabbits, recombinant human IL-1-α induced biphasic fevers, and during the second temperature elevation 3 hr later, a circulating pyrogenic material was detected by passive transfer of plasma to other rabbits. Induction of the biphasic fever was not caused by endotoxin contamination of the recombinant IL-1. The 3-hr circulating pyrogen was heat-labile and was not residual injected IL-1-α. Chromatographic separation of this plasma and biologic assay suggested that it was new IL-1 of rabbit origin. We next incubated human blood mononuclear cells with recombinant IL-1-α and measured the intracellular and extracellular levels of IL-1 by bioassay using the D10.G4.1 murine T cell line. In order to control for the carryover of recombinant IL-1-α used to stimulate the mononuclear cells (MNC), we used neutralizing antibodies that were specific for IL-1-α or IL-1-β. The results of these neutralizations showed that recombinant human IL-1-α induces the synthesis of IL-1-β in human MNC in vitro. These results were verified with a radioimmunoassay specific for IL-1-β. At concentrations of 100 ng/ml, IL-1-α induced prostaglandin E2 production in the MNC culture, and this was associated with decreased production of immunoreactive IL-1-β. Adding indomethacin to the cultures prevented the decreased production of IL-1-β induced by high concentrations of IL-1-α. Using non-adherent MNC, we observed an increase in IL-1-β as well as IL-1-α mRNA after 4 hr of exposure to recombinant IL-1-α. These results demonstrate that IL-1-α induces biologically active and immunoreactive IL-1-β from MNC in vitro and that the same concentrations of IL-1-α induce gene expression for both forms of IL-1. These studies suggest that IL-1 participates in an amplification event that is negatively influenced by its ability to induce prostaglandin E2 synthesis. These results may have clinical implications because they suggest that cyclo-oxygenase inhibitors, which are often administered to reduce IL-1-mediated inflammation, may also interfere with an intrinsic ability of IL-1 to down-regulate its own amplification.

AB - Interleukin 1 (IL-1) plays an important role in host defense mechanisms by increasing body temperature, inducing the synthesis of a variety of lymphokines and hepatic acute phase proteins and acting as a chemoattractant for lymphocytes. However, in some microenvironments such as injured tissue or joint spaces, elevated IL-1 levels may contribute to pathologic processes, for example, proliferation and fibrosis of tissue involved in pannus formation as well as degradation of matrix and abnormal tissue architecture. To investigate potential mechanisms that may lead to excessive production of IL-1, we have examined the ability of IL-1 to participate in an amplification event by inducing its own gene expression leading to synthesis of biologically active IL-1. When injected into rabbits, recombinant human IL-1-α induced biphasic fevers, and during the second temperature elevation 3 hr later, a circulating pyrogenic material was detected by passive transfer of plasma to other rabbits. Induction of the biphasic fever was not caused by endotoxin contamination of the recombinant IL-1. The 3-hr circulating pyrogen was heat-labile and was not residual injected IL-1-α. Chromatographic separation of this plasma and biologic assay suggested that it was new IL-1 of rabbit origin. We next incubated human blood mononuclear cells with recombinant IL-1-α and measured the intracellular and extracellular levels of IL-1 by bioassay using the D10.G4.1 murine T cell line. In order to control for the carryover of recombinant IL-1-α used to stimulate the mononuclear cells (MNC), we used neutralizing antibodies that were specific for IL-1-α or IL-1-β. The results of these neutralizations showed that recombinant human IL-1-α induces the synthesis of IL-1-β in human MNC in vitro. These results were verified with a radioimmunoassay specific for IL-1-β. At concentrations of 100 ng/ml, IL-1-α induced prostaglandin E2 production in the MNC culture, and this was associated with decreased production of immunoreactive IL-1-β. Adding indomethacin to the cultures prevented the decreased production of IL-1-β induced by high concentrations of IL-1-α. Using non-adherent MNC, we observed an increase in IL-1-β as well as IL-1-α mRNA after 4 hr of exposure to recombinant IL-1-α. These results demonstrate that IL-1-α induces biologically active and immunoreactive IL-1-β from MNC in vitro and that the same concentrations of IL-1-α induce gene expression for both forms of IL-1. These studies suggest that IL-1 participates in an amplification event that is negatively influenced by its ability to induce prostaglandin E2 synthesis. These results may have clinical implications because they suggest that cyclo-oxygenase inhibitors, which are often administered to reduce IL-1-mediated inflammation, may also interfere with an intrinsic ability of IL-1 to down-regulate its own amplification.

UR - http://www.scopus.com/inward/record.url?scp=0023201153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023201153&partnerID=8YFLogxK

M3 - Article

C2 - 3497982

AN - SCOPUS:0023201153

VL - 139

SP - 1902

EP - 1910

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -